Cargando…
Dual-energy spectral CT quantitative parameters for the differentiation of Glioma recurrence from treatment-related changes: a preliminary study
BACKGROUND: Differentiating glioma recurrence from treatment-related changes can be challenging on conventional imaging. We evaluated the efficacy of quantitative parameters measured by dual-energy spectral computed tomographic (CT) for this differentiation. METHODS: Twenty-eight patients were exami...
Autores principales: | Lv, Yanchun, Zhou, Jian, Lv, Xiaofei, Tian, Li, He, Haoqiang, Liu, Zhigang, Wu, Yi, Han, Lujun, Sun, Meili, Yang, Yadi, Guo, Chengcheng, Li, Cong, Zhang, Rong, Xie, Chuanmiao, Chen, Yinsheng, Chen, Zhongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966828/ https://www.ncbi.nlm.nih.gov/pubmed/31948400 http://dx.doi.org/10.1186/s12880-019-0406-5 |
Ejemplares similares
-
Identify glioma recurrence and treatment effects with triple-tracer PET/CT
por: Li, Cong, et al.
Publicado: (2021) -
Spectral CT: Preliminary Studies in the Liver Cirrhosis
por: Lv, Peijie, et al.
Publicado: (2012) -
Longitudinal brain structural alterations in patients with nasopharyngeal carcinoma early after radiotherapy
por: Guo, Zheng, et al.
Publicado: (2018) -
Aberrant Brain Activity at Early Delay Stage Post-radiotherapy as a Biomarker for Predicting Neurocognitive Dysfunction Late-Delayed in Patients With Nasopharyngeal Carcinoma
por: Yang, Yadi, et al.
Publicado: (2019) -
TIPS-13 A PHASE II STUDY OF NEOADJUVANT CAMRELIZUMAB AND APATINIB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMAS
por: Guo, Chengcheng, et al.
Publicado: (2023)